These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Experimental trial on the use of snake antivenom serum in transfusion accidents]. ALBERT SN Bull Actual Med; 1950; 3(4):236-41. PubMed ID: 24539579 [No Abstract] [Full Text] [Related]
25. Safe Handling of Snakes in an ED Setting. Cockrell M; Swanson K; Sanders A; Prater S; von Wenckstern T; Mick J J Emerg Nurs; 2017 Jan; 43(1):21-23. PubMed ID: 27842799 [TBL] [Abstract][Full Text] [Related]
26. Snake bite and antivenene. PRINGLE JA Health Horiz; 1948 Apr; 1():55-8. PubMed ID: 18863257 [No Abstract] [Full Text] [Related]
27. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines. Seddik SS; Wanas S; Helmy MH; Hashem M J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876 [TBL] [Abstract][Full Text] [Related]
28. Venomous snakes of Israel: ecology and snakebite. Kochva E Public Health Rev; 1998; 26(3):209-32. PubMed ID: 10444959 [TBL] [Abstract][Full Text] [Related]
29. The detection of hemorrhagic proteins in snake venoms using monoclonal antibodies against Virginia opossum (Didelphis virginiana) serum. Sánchez EE; García C; Pérez JC; De La Zerda SJ Toxicon; 1998 Oct; 36(10):1451-9. PubMed ID: 9723843 [TBL] [Abstract][Full Text] [Related]
30. [Bites of venomous snakes in Switzerland]. Plate A; Kupferschmidt H; Schneemann M Praxis (Bern 1994); 2016 Jun; 105(12):679-85; quiz 684-5. PubMed ID: 27269771 [TBL] [Abstract][Full Text] [Related]
31. Cross-neutralization by tiger snake (Notechis scutatus) antivenene and sea snake (Enhydrina schistosa) antivenene against several sea snake venoms. Baxter EH; Gallichio HA Toxicon; 1974 May; 12(3):273-8. PubMed ID: 4218381 [No Abstract] [Full Text] [Related]
32. [In Africa snake venom antivenins in short supply. Fatal risk for foreign tourists?]. Mebs D MMW Fortschr Med; 2002 Sep; 144(37):57. PubMed ID: 12380345 [No Abstract] [Full Text] [Related]
33. [The current situation and strategies of snake antivenomimmunoglobulins research and development]. Tian J; Fan QS; Zheng Y Yao Xue Xue Bao; 2015 Dec; 50(12):1573-80. PubMed ID: 27169279 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of Haffkine Institute polyvalent antivenin against Indian snake venoms. Kankonkar RC; Rao SS; Vad NE; Sant MV Indian J Med Res; 1972 Apr; 60(4):512-6. PubMed ID: 4633900 [No Abstract] [Full Text] [Related]
35. Antigenic relationship among antihemorrhagic factors from snake and opossum plasmas. Moura-da-Silva AM; Tanizaki MM Braz J Med Biol Res; 1989; 22(6):717-9. PubMed ID: 2620182 [TBL] [Abstract][Full Text] [Related]
36. [Technical notes and considerations concerning the titration of polyvalent antiophidic sera (V. aspis--V. berus--V. ammodytes)]. Piazzi SE; Riparbelli G Prog Immunobiol Stand; 1970; 4():456-65. PubMed ID: 5482189 [No Abstract] [Full Text] [Related]
37. Neutralization of tiger snake (Notechis scutatus) venom by serum from other Australian elapids. Thurn MJ; Broady KW; Mirtschin PJ Toxicon; 1993 Jul; 31(7):909-12. PubMed ID: 8212036 [TBL] [Abstract][Full Text] [Related]
38. Cross-neutralization of Micrurus fulvius fulvius (coral snake) venom by anti-Micrurus carinicauda dumerilii serum. Cohen P; Dawson JH; Seligmann EB Am J Trop Med Hyg; 1968 Mar; 17(2):308-10. PubMed ID: 4967162 [No Abstract] [Full Text] [Related]
39. Venomous snakes of Indiana: treatment of their bites. Parrish HM J Indiana State Med Assoc; 1967 Jun; 60(6):665-8. PubMed ID: 6068949 [No Abstract] [Full Text] [Related]